Laboratorios Farmacéuticos ROVI | Evaluate

August 01, 2023

US FDA approval and panel tracker: July 2023

Go or no go? Decision day looms for Eisai and Biogen

Leqembi seeks full approval, while Takeda hopes for a dengue green light and Verrica looks to break its streak of bad luck.

December 01, 2021

US FDA approval tracker: November 2021

October 29, 2021

Go or go go? J&J’s cell therapy heads to the FDA

November approval decisions loom for cilta-cel and Voxzogo, while molnupiravir heads for an advisory panel.

May 11, 2010

ROVI misses big with diabetic foot ulcer line extension